Most parents are unaware of a FDA advisory recommending that OTC cough and cold medications should not be give to children aged younger than 2 years.
Catching a Common Cold Gives Children COVID-19 Immunity
Exposure to a common seasonal coronavirus stimulates a memory T cell response that protects children against COVID-19. However, this immune response peaks at age 6.
Food Insecurity and the Dangers of Infant Formula Dilution
Earlier HPV vaccination associated with completed vaccine series
In a recent review, children with vaccination against human papillomavirus (HPV) initialized at a younger age were more likely to receive their full vaccination series.
Demystifying Infant Formula
The impact of mild sleep deprivation on the quality of life in children
As little as 39 minutes less sleep per night for 1 week can have an impact on the quality of life of children.
FDA extends approval of Evkeeza for homozygous familial hypercholesterolemia in young children
Evkeeza is the first angiopoietin-like 3 (ANGPTL3) inhibitor indicated for patients as young at 5 years to control high levels of low-density lipoprotein cholesterol (LDL-C) as a result of HoFH.
2 Clarke Drive Cranbury, NJ 08512